MPO and myelodysplastic syndrome: The MPO-MDS-Develop study was designed to assess the agreement and comparative discriminatory accuracy of a single-use customised lyophilised cocktail in a flow cytometry tube (namely, BD Lyotube Stain 468) and its laboratory-developed liquid reagent counterpart in quantifying peripheral blood neutrophil myeloperoxidase expression in patients referred for suspected MDS.